Searching for Dose Dense Fashion With Gcsf Support information? Find all needed info by using official links provided below.
http://www.lhsc.on.ca/Health_Professionals/LRCP/Oncology_Practice_Guidelines/LRCPGCSFalgorithmneutropeniaNov07.pdf
Algorithm for White Cell Growth Factor (G-CSF) Support Step 1. Evaluate patient for risk of febrile neutropenia (FN) ... *Dose Dense Chemotherapy1,4,5 *Standard Dose Chemo High Risk FN (>20%)1,4,5 • G-CSF secondary prophylaxis recommended if curative intent1,4 G-CSF primary prophylaxis recommended1,4 ...
https://www.medscape.com/viewarticle/540139_4
Oct 23, 2019 · Scheduling G-CSF Support With Dose-dense Chemotherapy . The timing and duration of G-CSF support are crucial to the optimal administration of dose-dense chemotherapy.
https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.21400
Sep 21, 2005 · Vinorelbine and docetaxel are active single agents in the treatment of nonsmall cell lung carcinoma (NSCLC) and may provide enhanced activity when combined in a dose‐dense fashion. The efficacy and safety of this combination was assessed when it was administered every 14 days with Filgrastim support in a community practice setting.Cited by: 9
https://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.561
561. Background: In randomized trials, administration of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with G-CSF support improved outcomes compared with every 3 week dosing in the adjuvant treatment of early breast cancer.However, the use of G-CSF in dd regimens is associated with increased cost and its utility for the T portion of this regimen is unclear.Author: Flavia Rocha Paes, Ines Maria Vaz Duarte Luis, Rafael Brant Costa, Otto Metzger Filho, Melissa E Hug...
https://link.springer.com/article/10.1007/s10549-008-0152-9
Aug 27, 2008 · Purpose Granulocyte-colony stimulating factor (G-CSF) was used in CALGB 9741 to support dose-dense sequential chemotherapy with doxorubicin and cyclophosphamide (AC) followed by paclitaxel (P) (Citron et al. J Clin Oncol 21:1431–1439, 2003). However, myelosuppression is not known to be dose or schedule limiting for paclitaxel.Cited by: 12
https://clinicaltrials.gov/ct2/show/NCT02698891
This research study is testing the safety and feasibility of delivering the 4 cycles of 'dose-dense' paclitaxel without the use of Neulasta (Pegfilgrastim) as a Granulocyte Colony-stimulating Factor (G-CSF) support.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846279/
Feb 27, 2010 · G-CSF prophylaxis is now recommended when the overall risk of febrile neutropenia (FN) due to regimen and individual patient factors is ≥20%, for supporting dose-dense and dose-intense chemotherapy and to help maintain dose density where dose reductions have been shown to compromise outcomes.Cited by: 93
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064124/
Feb 10, 2005 · The every 2 weeks schedule was delivered with granulocyte colony-stimulating factor (CSF) support. This trial is particularly informative because it was a pure test of the dose density concept; all patients received the same drugs, the same number of drug cycles, at the same cumulative dose and the same individual doses, in all arms of the trial.Cited by: 59
http://chemocare.com/chemotherapy/drug-info/g-csf.aspx
Chemocare.com uses generic names in all descriptions of drugs. Neupogen, Granix and Zarxio are trade names for filgrastim. Granulocyte - colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.
How to find Dose Dense Fashion With Gcsf Support information?
Follow the instuctions below:
- Choose an official link provided above.
- Click on it.
- Find company email address & contact them via email
- Find company phone & make a call.
- Find company address & visit their office.
